Vericel (VCEL) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$40.10
+0.1% on the day
+22.4% over 12 months
52-week range $29.34 – $48.31
Share price and insider trades
VCEL closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$7.9M
Insiders buying0
Insiders selling8
Vericel insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $7.9M of VCEL stock on the open market.
Get emailed when insiders cluster-buy stocks like VCEL
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
VCEL insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.0M | 5 |
| Q2 2026 | — | 0 | $3.7M | 17 |
| Q1 2026 | — | 0 | $2.3M | 6 |
| Q4 2025 | — | 0 | $929K | 6 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Vericel Corp insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $7.9M. 30 of 34 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 14SEC | Kevin F MclaughlinDirector | Sell Plan | 7,00018,300 held (−28%) | $44.53 | $312K | -9.9% | — |
| Aug 5SEC | Michael HalpinCOO | Sell Plan | 10,00016,394 held (−38%) | $46.84 | $468K | -14.4% | — |
| Jul 31SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 2,5001,078 held (−70%) | $48.90 | $122K | -18.0% | — |
| Jul 31SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 1,5001,078 held (−58%) | $48.90 | $73K | -18.0% | — |
| Jul 31SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 5001,078 held (−32%) | $48.90 | $24K | -18.0% | — |
| Jun 30SEC | Sean C. FlynnGeneral Counsel | Sell Plan | 15,0001,647 held (−90%) | $45.64 | $685K | -12.1% | — |
| Jun 30SEC | Jonathan Mark HopperChief Medical Officer | Sell Plan | 5,00075,753 held (−6%) | $45.00 | $225K | -10.9% | — |
| Jun 30SEC | Jonathan Mark HopperChief Medical Officer | Sell Plan | 5,00075,753 held (−6%) | $45.00 | $225K | -10.9% | — |
| Jun 30SEC | Joseph Anthony Mara Jr.CFO | Sell Plan | 5,00016,009 held (−24%) | $44.75 | $224K | -10.4% | — |
| Jun 30SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 2,500886 held (−74%) | $44.90 | $112K | -10.7% | — |
| Jun 30SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 232886 held (−21%) | $44.90 | $10K | -10.7% | — |
| Jun 22SEC | Sean C. FlynnGeneral Counsel | Sell Plan | 15,0001,647 held (−90%) | $40.21 | $603K | -0.3% | — |
| Jun 22SEC | Michael HalpinCOO | Sell Plan | 10,00016,248 held (−38%) | $40.24 | $402K | -0.3% | — |
| Jun 4SEC | Jonathan Mark HopperChief Medical Officer | Sell Plan | 4,37575,753 held (−5%) | $35.00 | $153K | +14.6% | — |
| May 15SEC | Kevin F MclaughlinDirector | Sell Plan | 3,50018,300 held (−16%) | $32.83 | $115K | +22.1% | — |
| May 15SEC | Kevin F MclaughlinDirector | Sell Plan | 3,50018,300 held (−16%) | $32.82 | $115K | +22.2% | — |
| May 13SEC | Paul K WottonDirector | Sell | 7,50018,802 held (−29%) | $32.64 | $245K | +22.9% | — |
| May 13SEC | Paul K WottonDirector | Sell | 2,50026,302 held (−9%) | $33.05 | $83K | +21.3% | — |
| May 8SEC | Joseph Anthony Mara Jr.CFO | Sell Plan | 5,00021,009 held (−19%) | $40.50 | $202K | -1.0% | — |
| May 8SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 3,4332,540 held (−57%) | $38.00 | $130K | +5.5% | — |
| May 8SEC | Jonathan SiegalPrincipal Accounting Officer | Sell Plan | 1,4221,118 held (−56%) | $40.50 | $58K | -1.0% | — |
| Apr 6SEC | Jonathan Mark HopperChief Medical Officer | Sell Plan | 3,47275,556 held (−4%) | $35.00 | $122K | +14.6% | — |
| Mar 25SEC | Heidi HagenDirector | Sell Plan | 15,00031,850 held (−32%) | $32.41 | $486K | +23.7% | — |
| Mar 4SEC | Sean C. FlynnGeneral Counsel | Sell Plan | 15,0001,262 held (−92%) | $35.36 | $530K | +13.4% | — |
| Mar 4SEC | Michael HalpinCOO | Sell Plan | 10,30516,080 held (−39%) | $35.30 | $364K | +13.6% | — |
| Mar 4SEC | Sean C. FlynnGeneral Counsel | Sell Plan | 6,4211,262 held (−84%) | $34.75 | $223K | +15.4% | — |
| Feb 13SEC | Kevin F MclaughlinDirector | Sell Plan | 7,00015,100 held (−32%) | $34.66 | $243K | +15.7% | — |
| Jan 9SEC | Michael HalpinCOO | Sell Plan | 10,00016,080 held (−38%) | $40.48 | $405K | -0.9% | — |
| Dec 4SEC | Paul K WottonDirector | Sell | 2,50028,102 held (−8%) | $37.97 | $95K | +5.6% | — |
| Dec 4SEC | Paul K WottonDirector | Sell | 2,50025,602 held (−9%) | $37.83 | $95K | +6.0% | — |
| Dec 4SEC | Jonathan Mark HopperChief Medical Officer | Sell Plan | 1,65266,562 held (−2%) | $39.14 | $65K | +2.5% | — |
| Nov 13SEC | Michael HalpinCOO | Sell Plan | 2,64215,932 held (−14%) | $40.41 | $107K | -0.8% | — |
| Nov 12SEC | Kevin F MclaughlinDirector | Sell Plan | 7,00015,100 held (−32%) | $38.59 | $270K | +3.9% | — |
| Nov 10SEC | Michael HalpinCOO | Sell Plan | 7,35815,932 held (−32%) | $40.47 | $298K | -0.9% | — |
Insiders at Vericel Corp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Michael HalpinCOO | — | $2.0M | Aug 5, 2026 | — |
| Sean C. FlynnGeneral Counsel | — | $2.0M | Jun 30, 2026 | — |
| Kevin F MclaughlinDirector | — | $1.1M | Aug 14, 2026 | — |
| Jonathan Mark HopperChief Medical Officer | — | $789K | Jun 30, 2026 | — |
| Jonathan SiegalPrincipal Accounting Officer | — | $531K | Jul 31, 2026 | — |
| Paul K WottonDirector | — | $517K | May 13, 2026 | — |
| Heidi HagenDirector | — | $486K | Mar 25, 2026 | — |
| Joseph Anthony Mara Jr.CFO | — | $426K | Jun 30, 2026 | — |
VCEL stock: common questions
Are Vericel Corp insiders buying VCEL stock?
In the past 12 months, 0 insiders reported open-market purchases of VCEL worth $0.
Are Vericel Corp insiders selling VCEL stock?
8 insiders reported sales worth $7.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is VCEL's 52-week range?
Over the past year VCEL has traded between $29.34 and $48.31. It last closed at $40.10 on Oct 9, 2026.